Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis-Reference-Cited by-同舟云学术

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis

Published:2015-10-14 Issue:1 Volume:30 Page:136-143
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Jawhar M,Schwaab J,Schnittger S,Meggendorfer M,Pfirrmann M,Sotlar K,Horny H-P,Metzgeroth G,Kluger S,Naumann N,Haferlach C,Haferlach T,Valent P,Hofmann W-K,Fabarius A,Cross N C P,Reiter A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2015284.pdf

Reference35 articles.

1. Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435–453.

2. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603–625.

3. Pardanani A . Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management. Am J Hematol 2013; 88: 612–624.

4. Theoharides TC, Valent P, Akin C . Mast cells, mastocytosis, and related disorders. N Engl J Med 2015; 373: 163–172.

5. Pardanani A . Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management. Am J Hematol 2015; 90: 250–262.

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mastocytosis: Principles and Pitfalls in the Diagnosis of a Unique Disease;IgMin Research;2024-08-06

2. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM;Blood Advances;2024-06-05

3. Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation;Cancer Genetics;2024-06

4. Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis;Journal of Hematology;2024-06

5. Nouveaux critères diagnostiques des mastocytoses : des progrès mais encore des interrogations;Bulletin de l'Académie Nationale de Médecine;2024-06